Bosutinib (Oral Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Bosutinib (Oral Route)

Drug Information provided by: Micromedex

US Brand Names

  • Bosulif

Description

Bosutinib is used to treat chronic myeloid leukemia (CML) that is Philadelphia chromosome-positive (Ph+). Leukemia is a type of cancer where the body makes abnormal white blood cells.

Bosutinib is an antineoplastic (cancer) medicine. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal cells may also be affected by bosutinib, other side effects can occur. Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of using it.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Tablet
Before Using
DR603681 Portions of this document last updated: Dec. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger